Skip to main content
. 2022 Nov 15;2(12):2636–2644. doi: 10.1021/jacsau.2c00448

Figure 1.

Figure 1

(a) 583 duocarmycin research reports were classified by a nine-point scheme, then structurally analyzed. (b) The A0-sized Poster S1 “Minard map” summarizes the structural evolution of >200 duocarmycin-derived agents from SAR to prodrugs and ADC.